Cargando…
Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far?
Undifferentiated carcinoma of the pancreas is an aggressive but rare tumor for which several other terms have been used to describe its histological appearance. In addition, as osteoclast-like giant cells may accompany undifferentiated carcinoma of the pancreas, the WHO Classification distinguishes...
Autores principales: | Demetter, Pieter, Maréchal, Raphaël, Puleo, Francesco, Delhaye, Myriam, Debroux, Sébastien, Charara, Fadi, Gomez Galdon, Maria, Van Laethem, Jean-Luc, Verset, Laurine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973287/ https://www.ncbi.nlm.nih.gov/pubmed/33747949 http://dx.doi.org/10.3389/fonc.2021.630086 |
Ejemplares similares
-
DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
por: Drouillard, A, et al.
Publicado: (2016) -
What we know so far
Publicado: (2021) -
Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells
por: Hur, Young Hoe, et al.
Publicado: (2011) -
Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far
por: Sawaya, Fadi, et al.
Publicado: (2019) -
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)